rs397516976
|
|
ACGTGATGGCCTC |
0.700 |
GeneticVariation |
CLINVAR |
Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas.
|
22761469 |
2012 |
rs397516981
|
|
TGGGCTCCCC |
0.700 |
CausalMutation |
CLINVAR |
Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu.
|
22325357 |
2012 |
rs397516981
|
|
TGGGCTCCCC |
0.700 |
CausalMutation |
CLINVAR |
Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas.
|
22761469 |
2012 |
rs397516982
|
|
GGGCTCCCCA |
0.700 |
GeneticVariation |
CLINVAR |
Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas.
|
22761469 |
2012 |
rs397516981
|
|
TGGGCTCCCC |
0.700 |
CausalMutation |
CLINVAR |
siRNA targeting against EGFR, a promising candidate for a novel therapeutic application to lung adenocarcinoma.
|
18334834 |
2008 |
rs397516979
|
|
GTGT |
0.700 |
GeneticVariation |
CLINVAR |
EGFR point mutation in non-small cell lung cancer is occasionally accompanied by a second mutation or amplification.
|
16863509 |
2006 |
rs397516980
|
|
TTAT |
0.700 |
GeneticVariation |
CLINVAR |
Lung adenocarcinoma harboring mutations in the ERBB2 kinase domain.
|
16825508 |
2006 |
rs397516980
|
|
TTAT |
0.700 |
GeneticVariation |
CLINVAR |
HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer.
|
16775247 |
2006 |
rs397516981
|
|
TGGGCTCCCC |
0.700 |
CausalMutation |
CLINVAR |
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation.
|
16638863 |
2006 |
rs397516979
|
|
GTGT |
0.700 |
GeneticVariation |
CLINVAR |
Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
|
15753357 |
2005 |
rs397516980
|
|
TTAT |
0.700 |
GeneticVariation |
CLINVAR |
Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
|
15753357 |
2005 |
rs397516981
|
|
TGGGCTCCCC |
0.700 |
CausalMutation |
CLINVAR |
Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
|
15753357 |
2005 |
rs397516982
|
|
GGGCTCCCCA |
0.700 |
GeneticVariation |
CLINVAR |
Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
|
15753357 |
2005 |
rs397516976
|
|
ACGTGATGGCCTC |
0.700 |
GeneticVariation |
CLINVAR |
Lung cancer: intragenic ERBB2 kinase mutations in tumours.
|
15457249 |
2004 |
rs397516982
|
|
GGGCTCCCCA |
0.700 |
GeneticVariation |
CLINVAR |
Lung cancer: intragenic ERBB2 kinase mutations in tumours.
|
15457249 |
2004 |
rs1555618025
|
|
ACGTGATGGCTTC |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs397516975
|
|
AGCATACGTGATG |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs397516977
|
|
ATACGTGATGGCT |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs397516978
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs397516979
|
|
GTTT |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs372043866
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Here, we report a case of an advanced chemotherapy-resistant NSCLC, harboring a novel HER3(V855A) somatic mutation homologous to the EGFR(L858R)activating mutation.
|
26689995 |
2016 |
rs372043866
|
|
|
0.020 |
GeneticVariation |
BEFREE |
It is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) carrying EGFR exon 19 deletions or exon 21 (L858R) mutations.
|
24844234 |
2014 |
rs758222990
|
|
|
0.010 |
GeneticVariation |
BEFREE |
This is the first case report describing a NSCLC patient harboring a rare <i>HER2</i> R896G mutation who responds to afatinib.
|
31849493 |
2019 |